Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
ophthalmic
Biotech
Annexon grabs $100M from a host of top VC firms
Annexon has grabbed a healthy $100 million round to take its clinical work closer to the finishing line as it tees up shots on multiple targets.
Ben Adams
Jul 2, 2020 8:10am
Inotek on its knees after back-to-back glaucoma trial flops
Jul 10, 2017 7:53am
Third Rock’s Eleven plots turnaround--or investor payout--via Roche deal
Aug 12, 2016 10:33am
After Pfizer buy, investors back team with $55M for next specialty pharma
Jul 27, 2016 1:45pm
